|
End-of-day quote
Other stock markets
|
||
| - USD | - |
|
| 07:58pm | Sector Update: Health Care Stocks Drop in Afternoon Trading | MT |
| 07:00pm | GSK Sues Pfizer, BioNTech Over mRNA Patents in Covid-19 Vaccines | MT |
(Reuters) - Drugmaker Pfizer Inc said it entered into an agreement with Goldman, Sachs & Co to buy back $5 billion of its stock.
Pfizer said the accelerated share repurchase was assumed in the forecast for the full year it provided last month.
Under the agreement, which forms a part of Pfizer's existing buyback authorization, about 150 million shares will be bought.
The settlement is expected during or prior to the third quarter.
Shares of the New York-based company closed at $33.06 on the New York Stock Exchange on Monday.
(Reporting by Anjali Rao Koppala in Bengaluru; Editing by Joyjeet Das)
| 1st Jan change | Capi. | |
|---|---|---|
| +24.17% | 562B | |
| -6.28% | 358B | |
| +19.20% | 322B | |
| +7.48% | 297B | |
| +13.45% | 219B | |
| +6.04% | 199B | |
| -10.51% | 196B | |
| -6.48% | 146B | |
| +2.07% | 117B |
PFIZER INC 
